Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap29.37M
Enterprise Value32.01M
CCEL
(NYSEAMERICAN)Cryo-Cell International, Inc.
$3.64-- (--)
Loading... - Market loading
Cryo-Cell International (CCEL) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)0.92
Forward Price/Sales0.94
Price/FCF (ttm)5.55
Price/OCF (ttm)5.32
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue1.01
EV/Earnings-13.18
EV/EBITDA97.99
EV/EBIT8.06
EV/FCF6.10
Stock Price
Current price, 52-week range, and moving averages
Current Price$3.64
1-Day Change1.69%
52-Week High$6.51
52-Week Low$2.72
52-Week Change-43.94%
YTD Change5.25%
1-Year Change-42.24%
50-Day MA$3.30
200-Day MA$4.14
Avg Volume (30 day)7.92K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding8.07M
Book Value per Share$-2.31
Net Cash per Share$-0.30
FCF per Share$0.65
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin76.63%
EBITDA Margin (ttm)1.03%
EBIT Margin (ttm)12.58%
Operating Margin (ttm)1.53%
Pretax Margin (ttm)-7.40%
Profit Margin (ttm)-7.70%
FCF Margin (ttm)16.63%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Assets (ttm)-3.94%
Return on Capital Employed (ttm)9.47%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue31.57M
Gross Profit24.19M
Operating Income482.39K
Pretax Income-2.34M
Net Income-2.43M
EBITDA326.69K
EBIT3.97M
Diluted EPS$-0.30
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow5.48M
Capital Expenditures230.47K
Free Cash Flow5.25M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth-1.84%
Dividend Growth-70.00%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)61.73M
Cash & Securities (mrq)319.03K
Net Cash (mrq)-2.41M
Net Cash per Share$-0.30
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)3.20M
Working Capital (mrq)-8.03M
Total Equity (mrq)-18.61M
Book Value per Share$-2.31
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)0.59
Quick Ratio (mrq)0.57
Debt/EBITDA (ttm)9.81
Debt/FCF (ttm)0.61
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.15
Dividend Yield4.16%
Payout Ratio (Earnings)303.03%
Payout Ratio (FCF)23.06%
Dividend Growth (YoY)-70.00%
Years of Dividend Growth1
Ex-Dividend DateMay 21, 2025
Pay DateMay 30, 2025
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-8.34%
FCF Yield18.02%
Buyback Yield0.58%
Total Shareholder Yield4.74%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-0.09
Piotroski F-Score6/9
Dividend Score35.00
Frequently Asked Questions About Cryo-Cell International Statistics
What are the key financial metrics for CCEL?
Cryo-Cell International, Inc. (CCEL) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is CCEL's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Cryo-Cell International is overvalued or undervalued.
How do I read CCEL's profitability ratios?
Cryo-Cell International's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do CCEL's debt ratios indicate?
The financial health section shows Cryo-Cell International's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is CCEL's dividend analysis?
The dividend section covers Cryo-Cell International's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.